申请人:Stieber Frank
公开号:US20100179148A1
公开(公告)日:2010-07-15
Compounds of the formula (I), in which R
1
, R
2
and R
3
have the meanings indicated in Claim
1,
are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
式(I)的化合物,其中R1、R2和R3具有权利要求1中指示的含义,是酪氨酸激酶的抑制剂,特别是Met激酶,并可用于治疗肿瘤。